The Drugs Controller General of India (DCGI) has approved Biological E for two clinical trials of its COVID-19 vaccine candidate Corbevax, according to an official notification from the ministry of science and technology on September 3.

Government gives Biological E nod to study its Covid vaccine Corbevax in children, teens

Biological E, based in Hyderabad, made news a few weeks ago when the government placed an order for 300 million doses of their COVID-19 vaccine Corbevax, which is currently pending approval from the pharma regulator.

COVID-19: Just $3.4 for two doses -  Made-in-India Biological E vaccine could be 90% effective

biological-e-vaccine

Biological E Vaccine, News on Biological E Vaccine, stories on Biological E Vaccine, articles on Biological E Vaccine, Biological E Vaccine stories at Wion, Biological E Vaccine news, Biological E Vaccine latest news

biological e-vaccine

Government gives Biological E nod to study its Covid vaccine Corbevax in children, teens

COVID-19: Just $3.4 for two doses - Made-in-India Biological E vaccine could be 90% effective